Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Clinical trial NCT06479863 · RECRUITING

Trial details

NCT number: NCT06479863
Sponsor: Austin Neuromuscular Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Sporadic Inclusion Body Myositis (sIBM)Idiopathic Inflammatory Myopathies

Start date: 2024-08-08
Primary completion: 2027-05-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.